SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
May 9, 2019
Document Date
May 9, 2019
Form Description
Securities offered to employees pursuant to employee benefit plans
Filing Group
Registration Statements
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.